Market Overview

Jim Cramer Weighs In On Sage Therapeutics, FireEye And Palo Alto

Share:
Related
A Peek Into The Markets: U.S. Stock Futures Mixed Ahead Of Wholesale Trade Report
7 Notable Biotechs With Data Expected By Year's End
Related FEYE
44 Biggest Movers From Friday
38 Stocks Moving In Friday's Mid-Day Session
New Research Coverage Highlights Trevena, Five Prime Therapeutics, Endocyte, FireEye, CSRA, and ... (GuruFocus)

On CNBC's "Mad Money", Jim Cramer spoke about SAGE Therapeutics Inc (NASDAQ: SAGE). He said that the company had some bad news on its phase III product. He wouldn't buy the stock and he would exit the position on any upswing.

Palo Alto Networks Inc (NYSE: PANW) had a great quarter and FireEye Inc (NASDAQ: FEYE) does great forensic work, thinks Cramer. His favorite stock in the space is Proofpoint Inc (NASDAQ: PFPT).

Posted-In: Mad MoneyCNBC Jim Cramer Media

 

Related Articles (PANW + FEYE)

View Comments and Join the Discussion!